Kairos Pharma KAPA Q2 2026 earnings

FAQ

When did Kairos Pharma report Q2 2026 earnings?

Kairos Pharma (KAPA) reported Q2 2026 earnings on August 12, 2026 before market open.

What were Kairos Pharma's Q2 2026 revenue and EPS?

Kairos Pharma reported eps of $-0.06 for Q2 2026.

Did Kairos Pharma beat estimates in Q2 2026?

EPS beat the consensus estimate of $-0.09 by $0.03.

How did Kairos Pharma's Q2 2026 results compare year-over-year?

Compared to the same quarter a year prior, eps grew 25.0% from $-0.08.

Where can I find Kairos Pharma's Q2 2026 SEC filings?

You can read the 10-Q periodic report (0001493152-26-037355) directly on SEC EDGAR. The filing index links above go to sec.gov.